bpc 157 and antibiotics Peptide RFK Jr on FDA action

The Phase 2 trial showed that participants at 8mg achieved an average of 22.8% body weight reduction at 48 weeks

Each semaglutide brand or formulation is FDA-approved for specific conditions and patient populations

Improve Skin Elasticity and Firmness Increase skin firmness and elasticity, reducing aging signs

Early studies suggest it may interact with biological pathways related to tissue integrity and gastrointestinal health, but additional human trials are needed

Response: We thank the commenter for their concern regarding the avoidance of perverse financial incentives

To meet the diagnostic criteria for cvEDS, a person must meet: Major criterion 1 AND family history compatible with autosomal recessive inheritance AND at least one other major criterion OR Major criterion 1 AND family history compatible with autosomal recessive inheritance AND at least two minor criteria Major Criteria Severe progressive cardiac-valvular problems (aortic valve, mitral valve) Skin involvement: skin hyperextensibility, atrophic scars, thin skin, easy bruising Joint hypermobility (generalized or restricted to small joints) Minor criteria Inguinal hernia Pectus deformity (especially excavatum) Joint dislocations Foot deformities: pes planus, pes planovalgus, hallux valgus Classical-like EDS (clEDS) If a person meets the diagnostic criteria for clEDS, genetic testing should be done to confirm the diagnosis